Tapolczay David 4
4 · CONDUIT PHARMACEUTICALS INC. · Filed Nov 20, 2024
Insider Transaction Report
Form 4
Tapolczay David
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-11-18$0.09/sh+840,000$77,196→ 840,000 totalExercise: $0.09Exp: 2034-11-18→ Common Stock (840,000 underlying)
Footnotes (2)
- [F1]Represents Options to purchase common stock, granted under the Issuer's 2023 Stock Incentive Plan.
- [F2]The Options vest as follows: (i) 50% on the grant date and (ii) 50% in equal annual installments on the first three anniversaries of the grant date.